These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37403701)

  • 1. Lobe-specific analysis of perioperative chemotherapy for non-small cell lung cancer patients.
    Lei X; Li T; Mao F; Ren F; Tang Q; Cao W; Zu L; Xu S
    Cancer Med; 2023 Aug; 12(16):16896-16905. PubMed ID: 37403701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of adjuvant chemotherapy on survival for patients with stage IB and IIA non-small cell lung cancer.
    Zhang P; Duan J; Bai H; Wang Z; Gao S; Tan F; Gao Y; Wang X; Wan R; Xu J; He X; Feng X; Yu R; Sun J; Zhao Z; Fei K; Li N; He J; Wang J
    Thorac Cancer; 2021 Jan; 12(1):30-39. PubMed ID: 33111432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should patients with stage IB non-small cell lung cancer receive adjuvant chemotherapy? A comparison of survival between the 8th and 7th editions of the AJCC TNM staging system for stage IB patients.
    Wang J; Wu N; Lv C; Yan S; Yang Y
    J Cancer Res Clin Oncol; 2019 Feb; 145(2):463-469. PubMed ID: 30474757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative chemotherapy significantly improves survival of elderly patients with stage IB-II non-small cell lung cancer: A population-based study.
    Liu W; Ma S; Shi P; Zhang Y; Li M
    Cancer Med; 2023 May; 12(10):11254-11263. PubMed ID: 37031456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propensity-matched analysis of adjuvant chemotherapy for completely resected Stage IB non-small-cell lung cancer patients.
    Li X; Zhang C; Sun Z; Yang F; Xiao R; Sui X; Jiang G; Zhong W; Wang J
    Lung Cancer; 2019 Jul; 133():75-82. PubMed ID: 31200832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of age on adjuvant chemotherapy after radical resection in patients with non-small cell lung cancer.
    Zhai X; Yang L; Chen S; Zheng Q; Wang Z
    Cancer Med; 2016 Sep; 5(9):2286-93. PubMed ID: 27367482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns and Predictors of Chemotherapy Use for Resected Non-Small Cell Lung Cancer.
    Rajaram R; Paruch JL; Mohanty S; Holl JL; Bilimoria KY; Ko CY; Winchester DP; Patel JD; DeCamp MM
    Ann Thorac Surg; 2016 Feb; 101(2):533-40. PubMed ID: 26507427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of adjuvant chemotherapy on survival of patients with stage IB non-small cell lung cancer with visceral pleural invasion.
    Xie J; Zhang X; Hu S; Peng WD; Xu B; Li Y; Zhang SJ; Li Q; Li C
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2231-2239. PubMed ID: 32533405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The present status of postoperative adjuvant chemotherapy for completely resected non-small cell lung cancer.
    Tsuboi M; Ohira T; Saji H; Miyajima K; Kajiwara N; Uchida O; Usuda J; Kato H
    Ann Thorac Cardiovasc Surg; 2007 Apr; 13(2):73-7. PubMed ID: 17505412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk stratification and adjuvant chemotherapy after radical resection based on the clinical risk scores of patients with stage IB-IIA non-small cell lung cancer.
    Zhai W; Duan F; Li D; Yan Q; Dai S; Zhang B; Wang J
    Eur J Surg Oncol; 2022 Apr; 48(4):752-760. PubMed ID: 34620508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline.
    Pisters KM; Evans WK; Azzoli CG; Kris MG; Smith CA; Desch CE; Somerfield MR; Brouwers MC; Darling G; Ellis PM; Gaspar LE; Pass HI; Spigel DR; Strawn JR; Ung YC; Shepherd FA; ;
    J Clin Oncol; 2007 Dec; 25(34):5506-18. PubMed ID: 17954710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of limited resection vs. inadequate adjuvant therapy in patients with pathologic stage II or III non-small cell lung cancer: results from the Korean Association of Lung Cancer Registry.
    Lee J; Cho JS; Kim YD; Ahn HY; ;
    Ann Palliat Med; 2024 Mar; 13(2):230-239. PubMed ID: 38509646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer.
    Scagliotti GV; Pastorino U; Vansteenkiste JF; Spaggiari L; Facciolo F; Orlowski TM; Maiorino L; Hetzel M; Leschinger M; Visseren-Grul C; Torri V
    J Clin Oncol; 2012 Jan; 30(2):172-8. PubMed ID: 22124104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer.
    Roth JA; Fossella F; Komaki R; Ryan MB; Putnam JB; Lee JS; Dhingra H; De Caro L; Chasen M; McGavran M
    J Natl Cancer Inst; 1994 May; 86(9):673-80. PubMed ID: 8158698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of platinum-based adjuvant chemotherapy in T2aN0 stage IB non-small cell lung cancer.
    Park SY; Lee JG; Kim J; Byun GE; Bae MK; Lee CY; Kim DJ; Chung KY
    J Cardiothorac Surg; 2013 Jun; 8():151. PubMed ID: 23759129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of adjuvant chemotherapy on survival for patients with completely resected high-risk stage IB NSCLC.
    Shen ZQ; Feng KP; Fang ZY; Xia T; Pan S; Ding C; Xu C; Ju S; Chen J; Li C; Zhao J
    J Cardiothorac Surg; 2024 Jan; 19(1):1. PubMed ID: 38166960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant chemotherapy may improve long-term outcomes in stage IB non-small cell lung cancer patients with previous malignancies: A propensity score-matched analysis.
    Zhou K; Zhao Y; Liang L; Cao J; Lin H; Peng Z; Mei J
    Front Oncol; 2022; 12():938195. PubMed ID: 36119504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival benefit of thermal ablation combined with chemotherapy for the treatment of stage IV nonsmall cell lung cancer: a propensity-matched analysis.
    Yang H; Li M; Mei T
    Int J Hyperthermia; 2022; 39(1):348-357. PubMed ID: 35164638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do older patients with stage IB non-small-cell lung cancer obtain survival benefits from surgery? A propensity score matching study using SEER data.
    Ye X; Liu Y; Yang J; Wang Y; Cui X; Xie H; Song L; Ding Z; Zhai R; Han Y; Yang L; Zhang H
    Eur J Surg Oncol; 2022 Sep; 48(9):1954-1963. PubMed ID: 35379544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.
    Strauss GM; Herndon JE; Maddaus MA; Johnstone DW; Johnson EA; Harpole DH; Gillenwater HH; Watson DM; Sugarbaker DJ; Schilsky RL; Vokes EE; Green MR
    J Clin Oncol; 2008 Nov; 26(31):5043-51. PubMed ID: 18809614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.